CA2011943A1 - Compositions for the preparation of dosage-form active vitamins d3 and process for preparing stable dosage-form active vitamins d3 by using the same - Google Patents
Compositions for the preparation of dosage-form active vitamins d3 and process for preparing stable dosage-form active vitamins d3 by using the sameInfo
- Publication number
- CA2011943A1 CA2011943A1 CA002011943A CA2011943A CA2011943A1 CA 2011943 A1 CA2011943 A1 CA 2011943A1 CA 002011943 A CA002011943 A CA 002011943A CA 2011943 A CA2011943 A CA 2011943A CA 2011943 A1 CA2011943 A1 CA 2011943A1
- Authority
- CA
- Canada
- Prior art keywords
- dosage
- form active
- preparation
- vitamin
- active vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60554/1989 | 1989-03-13 | ||
| JP1060554A JPH02240024A (ja) | 1989-03-13 | 1989-03-13 | 活性型ビタミンｄ↓３類製剤用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2011943A1 true CA2011943A1 (en) | 1990-09-13 |
Family
ID=13145623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002011943A Abandoned CA2011943A1 (en) | 1989-03-13 | 1990-03-12 | Compositions for the preparation of dosage-form active vitamins d3 and process for preparing stable dosage-form active vitamins d3 by using the same |
Country Status (6)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2845342B2 (ja) * | 1990-04-28 | 1999-01-13 | 大正製薬株式会社 | ビタミンｄ▲下３▼誘導体含有固形製剤組成物 |
| JPH04198129A (ja) * | 1990-11-28 | 1992-07-17 | Sumitomo Pharmaceut Co Ltd | 活性型ビタミンｄ↓３類含有組成物 |
| IL103224A (en) * | 1992-09-18 | 1998-08-16 | Teva Pharma | Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
| HUE056937T2 (hu) | 2006-02-03 | 2022-04-28 | Opko Renal Llc | A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal |
| US8329677B2 (en) | 2006-06-21 | 2012-12-11 | Cytochroma, Inc. | Method of treating and preventing secondary hyperparathyroidism |
| CN101600431B (zh) * | 2006-12-07 | 2011-09-07 | 第一三共株式会社 | 具有改进贮存稳定性的药物组合物 |
| US9034860B2 (en) | 2006-12-07 | 2015-05-19 | Daiichi Sankyo Company, Limited | Pharmaceutical composition containing low-substituted hydroxypropyl cellulose |
| PL2481400T3 (pl) | 2007-04-25 | 2015-04-30 | Opko Ip Holdings Ii Inc | Sposoby i kompozycje dawki doustnej do kontrolowanego uwalniania związku będącego witaminą D |
| EP2148683A4 (en) | 2007-04-25 | 2012-09-12 | Proventiv Therapeutics Llc | SAFE AND EFFECTIVE METHOD OF TREATING AND PREVENTING SECONDARY HYPERPARATHYROIDIA IN CHRONIC RENAL DISEASES |
| PL2148684T3 (pl) | 2007-04-25 | 2013-06-28 | Cytochroma Inc | Sposób leczenia niedoboru i deficytu witaminy D |
| EP3112476B1 (en) | 2008-04-02 | 2023-08-02 | EirGen Pharma Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| WO2011123476A1 (en) | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| JP7034595B2 (ja) * | 2016-03-23 | 2022-03-14 | 株式会社ファンケル | ビタミンｄ３安定化組成物 |
| EA201892189A1 (ru) | 2016-03-28 | 2019-03-29 | Опко Айэлэнд Глобал Холдингз, Лимитед | Способы лечения витамином d |
| JP7085105B2 (ja) * | 2016-11-10 | 2022-06-16 | 日産化学株式会社 | ビタミンｄ３誘導体の製剤 |
| KR102583517B1 (ko) * | 2016-12-28 | 2023-09-26 | 추가이 세이야쿠 가부시키가이샤 | Ed-71의 고체 분산체 및 유분 분산체를 포함하는 의약 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62149619A (ja) * | 1985-09-05 | 1987-07-03 | Teijin Ltd | 活性型ビタミンｄ３類注射用組成物 |
| JPS6483019A (en) * | 1987-09-25 | 1989-03-28 | Sunstar Inc | Composition used in oral cavity for orthodontic therapy of tooth |
| JPS6425723A (en) * | 1988-07-07 | 1989-01-27 | Teijin Ltd | Production of active type vitamin d3 composition |
| JP2525478B2 (ja) * | 1989-03-01 | 1996-08-21 | 帝人株式会社 | 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤 |
-
1989
- 1989-03-13 JP JP1060554A patent/JPH02240024A/ja active Granted
-
1990
- 1990-03-12 CA CA002011943A patent/CA2011943A1/en not_active Abandoned
- 1990-03-12 KR KR1019900003246A patent/KR900013964A/ko not_active Ceased
- 1990-03-13 ES ES90104750T patent/ES2057225T3/es not_active Expired - Lifetime
- 1990-03-13 DE DE9090104750T patent/DE69001573T2/de not_active Expired - Fee Related
- 1990-03-13 EP EP90104750A patent/EP0387808B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0387808A3 (en) | 1991-04-03 |
| DE69001573T2 (de) | 1993-08-26 |
| ES2057225T3 (es) | 1994-10-16 |
| JPH0587050B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-12-15 |
| EP0387808A2 (en) | 1990-09-19 |
| DE69001573D1 (de) | 1993-06-17 |
| JPH02240024A (ja) | 1990-09-25 |
| KR900013964A (ko) | 1990-10-22 |
| EP0387808B1 (en) | 1993-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2011943A1 (en) | Compositions for the preparation of dosage-form active vitamins d3 and process for preparing stable dosage-form active vitamins d3 by using the same | |
| EP0309157B1 (en) | Sustained release etodolac | |
| DE69824277T2 (de) | Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten | |
| EP0317878B1 (de) | Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen | |
| KR950008764B1 (ko) | 서방성 의약 제제 | |
| EP0263083B1 (en) | Coating membrane and compositions prepared therefrom | |
| US4198391A (en) | Pharmaceutical compositions | |
| US4301146A (en) | Stabilization of 16-oxygenated prostanoic acid derivatives | |
| EP0193287A2 (en) | Etoposide preparations | |
| HUT49280A (en) | Ointment for the peroral administration of medicine and process for producing the composition | |
| IE51637B1 (en) | Pharmaceutical preparation | |
| US4366145A (en) | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation | |
| US4666919A (en) | Stabilized pharmaceutical composition containing an isocarbostyril derivative | |
| NZ200244A (en) | Gallopamil or verapamil as calcium-antagonistic active compounds in sustained release pharmaceutical compositions | |
| KR100635018B1 (ko) | (7α, 17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온의 고순도 화합물을 제조하는 방법 | |
| US3966949A (en) | Pharmaceutical compositions and preparing same | |
| JPS6181753A (ja) | 粉立ちしない抗生、抗コクシジア予備混合組成物およびその製造方法 | |
| EP0116358B1 (de) | Komplexe von Prostaglandinen | |
| EP0063884B1 (en) | Oxazole derivatives, their preparation and use | |
| EP0016610A2 (en) | Method for preserving an E-type prostaglandin and stabilized PGE-type in triethyl citrate solution | |
| US5258375A (en) | Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate | |
| JPH07550B2 (ja) | 精油含有軟カプセル | |
| WO1999020276A1 (fr) | Composition medicamenteuse stable | |
| JPH0344052B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US3873727A (en) | Stabilization of molded sublingual nitroglycerin tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |